In vitro absorption studies and their relevance to absorption from the GI tract

[1]  J. Fix,et al.  Use of everted intestinal rings for in vitro examination of oral absorption potential. , 1994, Journal of pharmaceutical sciences.

[2]  T. Garrigues,et al.  Biophysical models as an approach to study passive absorption in drug development: 6-fluoroquinolones. , 1995, Journal of pharmaceutical sciences.

[3]  P. Kornguth,et al.  Histological reevaluation of everted gut technique for studying intestinal absorption. , 1970, European journal of pharmacology.

[4]  G. Semenza,et al.  A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of D-glucose and choline transport systems. , 1978, Biochimica et biophysica acta.

[5]  R. Kimura,et al.  Active transport of 3-O-methyl-glucose by the small intestine in chronically catheterized rats. , 1995, The Journal of clinical investigation.

[6]  H H USSING,et al.  Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. , 1951, Acta physiologica Scandinavica.

[7]  P. Artursson,et al.  Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. , 1990, Journal of pharmaceutical sciences.

[8]  H. Lennernäs,et al.  Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo , 1996 .

[9]  P. Artursson,et al.  A method for the determination of cellular permeability coefficients and aqueous boundary layer thickness in monolayers of intestinal epithelial caco 2 cells grown in permeable filter chambers , 1991 .

[10]  T. Terasaki,et al.  Mechanisms of intestinal absorption of the antibiotic, fosfomycin, in brush-border membrane vesicles in rabbits and humans. , 1992, Journal of pharmacobio-dynamics.

[11]  T. Kararli.  Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.

[12]  A. Thomson,et al.  Dietary fat selectively alters transport properties of rat jejunum. , 1986, Journal of Clinical Investigation.

[13]  I. Matthes,et al.  Muscusmodelle zur Untersuchung von intestinalen Absorptionsmechanismen. 4: Vergleich des Mucusmodells mit Absorptionsmodellen in vivo und in situ zur Vorhersage intestinaler Wirkstoffabsorption , 1992 .

[14]  H. G. Windmueller,et al.  Vascular perfusion of isolated rat gut: norepinephrine and glucocorticoid requirement. , 1970, The American journal of physiology.

[15]  B. Levet-Trafit,et al.  Estimation of oral drug absorption in man based on intestine permeability in rats. , 1996, Life sciences.

[16]  H Lennernäs,et al.  Jejunal permeability and hepatic extraction of fluvastatin in humans , 1996, Clinical pharmacology and therapeutics.

[17]  C. Pidgeon,et al.  IAM chromatography: an in vitro screen for predicting drug membrane permeability. , 1995, Journal of medicinal chemistry.

[18]  S. Lundin,et al.  Bidirectional small-intestinal permeability in the rat to some common marker molecules in vitro. , 1994, Scandinavian journal of gastroenterology.

[19]  T. H. Wilson,et al.  The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface , 1954, The Journal of physiology.

[20]  H. Daniel,et al.  Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells. , 1996, The Journal of pharmacology and experimental therapeutics.

[21]  R. van der Meer,et al.  UvA-DARE ( Digital Academic Repository ) Differential in vivo and in vitro intestinal permeability to lactulose and mannitol in animals and humans : a hypothesis , 2004 .

[22]  W. Higuchi,et al.  Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes , 1980 .

[23]  G. Amidon,et al.  Noncompetitive inhibition of cephradine uptake by enalapril in rabbit intestinal brush-border membrane vesicles: an enalapril specific inhibitory binding site on the peptide carrier. , 1994, The Journal of pharmacology and experimental therapeutics.

[24]  Pravin Chaturvedi,et al.  Design principles for orally bioavailable drugs , 1996 .

[25]  W. L. Chiou.  The validation of the intestinal permeability approach to predict oral fraction of dose absorbed in humans and rats. , 1995, Biopharmaceutics & drug disposition.

[26]  James Blanchard,et al.  Reevaluation of the absorption of carbenoxolone using an in situ rat intestinal technique. , 1990, Journal of pharmaceutical sciences.

[27]  R. Dorr,et al.  Absorption enhancement of melanotan-l: comparison of the caco-2 and rat in situ models , 1995 .

[28]  J. Dressman,et al.  Absorption of ACE inhibitors from small intestine and colon. , 1994, Journal of pharmaceutical sciences.

[29]  J. Horton,et al.  Allopurinol prevents intestinal permeability changes after ischemia-reperfusion injury. , 1992, Journal of pediatric surgery.

[30]  Thomas J. Raub,et al.  Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. , 1989, Gastroenterology.

[31]  K. Luthman,et al.  Correlation of drug absorption with molecular surface properties. , 1996, Journal of pharmaceutical sciences.

[32]  R. Kimura,et al.  The effect of surgical bowel manipulation and anesthesia on intestinal glucose absorption in rats. , 1995, The Journal of clinical investigation.

[33]  V. Lee,et al.  Segmental differences in drug permeability, esterase activity and ketone reductase activity in the albino rabbit intestine. , 1993, Journal of drug targeting.

[34]  S. Lundin,et al.  Regional small-intestinal permeability in vitro to different-sized dextrans and proteins in the rat. , 1993, Scandinavian journal of gastroenterology.

[35]  M. Rathbone,et al.  Mechanisms, barriers and pathways of oral mucosal drug permeation , 1993 .

[36]  R. Oberle,et al.  Evaluation of mucosal damage of surfactants in rat jejunum and colon. , 1995, Journal of pharmacological and toxicological methods.

[37]  R. Conradi,et al.  The relationship between peptide structure and transport across epithelial cell monolayers , 1992 .

[38]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[39]  T. Ma,et al.  IEC-18, a nontransformed small intestinal cell line for studying epithelial permeability. , 1992, The Journal of laboratory and clinical medicine.

[40]  D. Breimer,et al.  Intestinal drug absorption enhancement: an overview. , 1989, Pharmacology & therapeutics.

[41]  A. Ungell,et al.  Effects of enzymatic inhibition and increased paracellular shunting on transport of vasopressin analogues in the rat. , 1992, Journal of pharmaceutical sciences.

[42]  Ronald T. Borchardt,et al.  Models for Assessing Drug Absorption and Metabolism , 1996, Pharmaceutical Biotechnology.

[43]  C Silipo,et al.  Calculation of hydrophobic constant (log P) from pi and f constants. , 1975, Journal of medicinal chemistry.